W
WAVEMAN · COMPANY
COSM · Cosmos Health Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

COSM

Cosmos Health Inc.
WHOLESALE & RETAIL · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · CIK 0001474167
C-SUITE BUYING · 2☆ WATCH
INSIDER NET · 180D
$459.2K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
2
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
10
13F, latest reported quarter
REVENUE GROWTH
+19.9%
XBRL, annual
NET MARGIN
-29.3%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$459.2K over 180 days
+$459.2K over 90 days · +$417.2K of it by a 10%+ holder
more than 87% of Wholesale & Retail
CONGRESS
no member of Congress has reported trading it
FUNDS
10 funds added or opened last quarter
below 83% of Wholesale & Retail
REVENUE
+19.9% year over year
more than 85% of Wholesale & Retail
MARGIN
-29.3% net margin
below 86% of Wholesale & Retail
BUYBACKS
$513.0K repurchased, FY to 2026-06-30
below 92% of Wholesale & Retail
SHORT
4.1% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
more than 60% of Wholesale & Retail
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -66.3%
-66.3%12M
-78%-33%+13%+58%2025-092025-102025-122026-032026-052026-072026-09 2026-01-14 · Siokas Grigorios bought $222.1K2026-01-20 · Siokas Grigorios bought $176.7K2026-06-10 · Siokas Grigorios bought $161.3K2026-02-12 · Siokas Grigorios bought $143.8K2026-07-29 · Siokas Grigorios bought $140.0K2026-02-11 · Siokas Grigorios bought $119.4K2026-01-08 · Siokas Grigorios bought $81.2K2026-01-06 · Siokas Grigorios bought $72.3K2025-12-15 · Siokas Grigorios bought $70.8K2026-07-30 · Siokas Grigorios bought $70.0K2026-01-07 · Siokas Grigorios bought $64.9K2026-01-12 · Siokas Grigorios bought $56.6K2025-11-28 · Siokas Grigorios bought $48.9K2026-06-11 · Siokas Grigorios bought $45.9K2026-01-23 · Siokas Grigorios bought $45.2K2025-12-19 · Siokas Grigorios bought $43.3K2026-06-16 · Terzis Georgios bought $42.0K2025-11-19 · Siokas Grigorios bought $40.0K2025-11-21 · Siokas Grigorios bought $38.1K2025-11-25 · Siokas Grigorios bought $35.1K2025-11-20 · Siokas Grigorios bought $31.8K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $459.2K bought by insiders over 180 days, 10 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Cosmos Health Inc. insiders bought a net $459.2K of stock across 74 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Siokas Grigorios
Chief Executive Officer
BUY
2026-07-30
349,825.0
$70.0K
Siokas Grigorios
Chief Executive Officer
BUY
2026-07-29
766,284.0
$140.0K
Terzis Georgios
Chief Financial Officer
BUY
2026-06-16
168,135.0
$42.0K
Siokas Grigorios
Chief Executive Officer
BUY
2026-06-11
218,447.0
$45.9K
Siokas Grigorios
Chief Executive Officer
BUY
2026-06-10
701,447.0
$161.3K
74 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 69 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
UBS Group AG
594,462.0 sh
$110.0K
VANGUARD FIDUCIARY TRUST CO
333,842.0 sh
$61.8K
JANE STREET GROUP, LLC
289,287.0 sh
$53.4K
GEODE CAPITAL MANAGEMENT, LLC
282,094.0 sh
$52.1K
BlackRock, Inc.
267,797.0 sh
$49.5K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$43.8K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$44.4K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$11.2K POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$8.5K POSITION · AS OF 2026-02-28
0.0%
Fidelity Nasdaq Composite Index Fund
$875 POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$65.3M$54.4M$53.4M$50.3M
GROSS PROFIT$7.9M$4.3M$4.3M$6.0M
OPERATING INCOME$-16.7M$-15.5M$-21.8M$-7.5M
NET INCOME$-19.1M$-16.2M$-18.5M$-13.8M
EPS (DILUTED)-0.63-1.17-2.15-33.16
OPERATING CASH FLOW$-8.4M$-7.7M$-15.6M$-14.9M
CASH$715.7K$315.1K$20.7M
LONG-TERM DEBT$3.8M$4.1M$4.6M$5.0M
BUYBACKS$0$100.5K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →